AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
TELMISARTAN+AMLODIPINE in Tunisia
8 products registered with DPM — 0 active, 8 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TELMYCOR-AM Comprimé / 40 mg/5 mg | 9403171 | THERA | expired | 1 Mar 2023 |
| TELMYCOR-AM Comprimé / 80 mg/5 mg | 9403173 | THERA | expired | 1 Mar 2023 |
| TELMYCOR-AM Comprimé / 40 mg/10 mg | 9403172 | THERA | expired | 1 Mar 2023 |
| TELMYCOR-AM Comprimé / 80 mg/10 mg | 9403174 | THERA | expired | 1 Mar 2023 |
| TWYNSTA Comprimé / 80 mg/5 mg | 11533054 | BOEHRINGER ING.INT.GmbH | expired | 12 Jan 2017 |
| TWYNSTA Comprimé / 80 mg/10 mg | 11533053 | BOEHRINGER ING.INT.GmbH | expired | 4 Jan 2017 |
| TWYNSTA Comprimé / 40 mg/5 mg | 11533051 | BOEHRINGER ING.INT.GmbH | expired | 18 Oct 2016 |
| TWYNSTA Comprimé / 40 mg/10 mg | 11533052 | BOEHRINGER ING.INT.GmbH | expired | 18 Oct 2016 |
TELMISARTAN+AMLODIPINE — DPM Registration Details
DPM (Tunisia) has 8 registered products containing TELMISARTAN+AMLODIPINE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track TELMISARTAN+AMLODIPINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.